Prostate Cancer Reports
54

Volume 6 Number 2
February 2018

.

Home > Prostate Cancer Reports > Volume 6, Year 2018 > Number 2, February



CONTENTS



DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS, PREVENTION
OVERALL MANAGEMENT
PROGNOSIS
TREATMENT



DIAGNOSIS


Buergy D, Sertdemir M, Weidner A, Shelan M, Lohr F, Wenz F, Schoenberg SO, Attenberger UI.
Detection of Local Recurrence with 3-Tesla MRI After Radical Prostatectomy: A Useful Method for Radiation Treatment Planning?
In Vivo. 2018 Jan-Feb;32(1):125-131.
Source | Abstract | Full text | Similar articles




Calais J, Fendler WP, Herrmann K, Eiber M, Ceci F.
Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 18F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence.
J Nucl Med. 2017 Dec 14. pii: jnumed.117.203257. doi: 10.2967/jnumed.117.203257. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Calais J, Fendler WP, Eiber M, Gartmann J, Chu FI, Nickols NG, Reiter RR, Rettig MB, Marks LS, Ahlering TE, Huynh L, Slavik R, Gupta P, Quon A, Allen-Auerbach MS, Czernin J, Herrmann K.
Actual impact of 68Ga-PSMA-11 PET/CT on the management of prostate cancer patients with biochemical recurrence.
J Nucl Med. 2017 Dec 14. pii: jnumed.117.202945. doi: 10.2967/jnumed.117.202945. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Epstein JI.
Prostate cancer grading: a decade after the 2005 modified system.
Mod Pathol. 2018 Jan;31(S1):S47-63. doi: 10.1038/modpathol.2017.133.
Source | Abstract | Full text | Similar articles




Grivas N, Hinnen K, de Jong J, Heemsbergen W, Moonen L, Witteveen T, van der Poel H, Heijmink S.
Seminal vesicle invasion on multi-parametric magnetic resonance imaging: Correlation with histopathology.
Eur J Radiol. 2018 Jan;98:107-112. doi: 10.1016/j.ejrad.2017.11.013. Epub 2017 Nov 21.
Source | Abstract | Full text | Similar articles




Gupta SK, Watson T, Denham J, Shakespeare TP, Rutherford N, McLeod N, Picton K, Ainsworth P, Bonaventura T, Martin JM.
Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography for Prostate Cancer: Distribution of Disease and Implications for Radiation Therapy Planning.
Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):701-709. doi: 10.1016/j.ijrobp.2017.06.2448. Epub 2017 Jun 27.
Source | Abstract | Full text | Similar articles




Gupta M, Choudhury PS, Rawal S, Goel HC, Singh A, Talwar V, Sahoo SK.
Risk stratification and staging in prostate cancer with prostatic specific membrane antigen PET/CTObjective: A one-stop-shop.
Hell J Nucl Med. 2017 Sep-Dec;20 Suppl:156.
Source | Abstract | Full text | Similar articles




He M, Liu H, Cao J, Wang Q, Xu H, Wang Y.
Predicting castration-resistant prostate cancer after combined androgen blockade.
Oncotarget. 2017 Nov 1;8(62):105458-105462. doi: 10.18632/oncotarget.22246. eCollection 2017 Dec 1.
Source | Abstract | Full text | Similar articles




Jadvar H, Ballas LK.
PSMA PET: Transformational Change in Prostate Cancer Management?
J Nucl Med. 2017 Dec 14. pii: jnumed.117.203604. doi: 10.2967/jnumed.117.203604. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Nguyen DP, Vertosick EA, Sharma V, Corradi RB, Vilaseca A, Takeda T, Sjoberg DD, Benfante N, Fine SW, Reuter VE, Scardino PT, Eastham JA, Karnes RJ, Touijer KA.
Does subclassification of pathologically organ-confined (pT2) prostate cancer provide prognostic discrimination of outcomes after radical prostatectomy?
J Urol. 2018 Jan 4. pii: S0022-5347(18)30005-3. doi: 10.1016/j.juro.2017.12.056. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Sauer M, Weinrich JM, Fraune C, Salomon G, Tennstedt P, Adam G, Beyersdorff D.
Accuracy of multiparametric MR imaging with PI-RADS V2 assessment in detecting infiltration of the neurovascular bundles prior to prostatectomy.
Eur J Radiol. 2018 Jan;98:187-192. doi: 10.1016/j.ejrad.2017.11.019. Epub 2017 Nov 27.
Source | Abstract | Full text | Similar articles




Sertdemir M, Weidner AM, Schoenberg SO, Morelli JN, Haecker A, Kirchner M, Weiss C, Hausmann D, Dinter DJ, Attenberger UI.
Is There a Role for Functional MRI for the Assessment of Extracapsular Extension in Prostate Cancer?
Anticancer Res. 2018 Jan;38(1):427-432.
Source | Abstract | Full text | Similar articles




von Klot CJ, Merseburger AS, Böker A, Schmuck S, Ross TL, Bengel FM, Kuczyk MA, Henkenberens C, Christiansen H, Wester HJ, Solass W, Lafos M, Derlin T.
68Ga-PSMA PET/CT Imaging Predicting Intraprostatic Tumor Extent, Extracapsular Extension and Seminal Vesicle Invasion Prior to Radical Prostatectomy in Patients with Prostate Cancer.
Nucl Med Mol Imaging. 2017 Dec;51(4):314-322. doi: 10.1007/s13139-017-0476-7. Epub 2017 Mar 7.
Source | Abstract | Full text | Similar articles




Xie W, Regan MM, Sweeney CJ.
Reply to Y. Zhu et al
J Clin Oncol. 2017 Dec DOI: 10.1200/JCO.2017.76.2872
Source | Abstract | Full text | Similar articles




Zhu Y, Ye D.
Measurement of Metastasis in the Follow-Up of Localized Prostate Cancer.
J Clin Oncol. 2017 Dec 21:JCO2017762005. doi: 10.1200/JCO.2017.76.2005. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



EPIDEMIOLOGY, RISK FACTORS, PREVENTION


Ma Y, Brusselaers N.
Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk.
Prostate Cancer Prostatic Dis. 2017 Dec 19. doi: 10.1038/s41391-017-0021-x. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Zhang T, Yang X, Zhou J, Liu P, Wang H, Li A, Zhou Y.
Benzodiazepine drug use and cancer risk: a dose-response meta analysis of prospective cohort studies.
Oncotarget. 2017 Oct 19;8(60):102381-102391. doi: 10.18632/oncotarget.22057. eCollection 2017 Nov 24.
Source | Abstract | Full text | Similar articles



OVERALL MANAGEMENT


Bernstein AN, Shoag JE, Golan R, Halpern JA, Schaeffer EM, Hsu WC, Nguyen PL, Sedrakyan A, Chen RC, Eggener SE, Hu JC.
Contemporary Incidence & Outcomes of Prostate Cancer Lymph Node Metastases.
J Urol. 2017 Dec 26. pii: S0022-5347(17)78181-5. doi: 10.1016/j.juro.2017.12.048. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Leslie SW, Siref LE.
Cancer, Prostate.
StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun-2017 Dec 15.
Source | Abstract | Full text | Similar articles




Sanda MG, Cadeddu JA, Kirkby E, Chen RC, Crispino T, Fontanarosa J, Freedland SJ, Greene K, Klotz LH, Makarov DV, Nelson JB, Rodrigues G, Sandler HM, Taplin ME, Treadwell JR.
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options.
J Urol. 2018 Jan 10. pii: S0022-5347(18)30014-4. doi: 10.1016/j.juro.2018.01.002. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Virgolini I, Decristoforo C, Haug A, Fanti S, Uprimny C.
Current status of theranostics in prostate cancer.
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):471-495. doi: 10.1007/s00259-017-3882-2. Epub 2017 Dec 28.
Source | Abstract | Full text | Similar articles



PROGNOSIS


García-Barreras S, Rozet F, Nunes-Silva I, Srougi V, Sanchez-Salas R, Barret E, Galiano M, Cathelineau X.
Predictive factors and the important role of detectable prostate-specific antigen for detection of clinical recurrence and cancer-specific mortality following robot-assisted radical prostatectomy.
Clin Transl Oncol. 2017 Dec 14. doi: 10.1007/s12094-017-1812-1. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Jackson WC, Suresh K, Tumati V, Allen SG, Dess RT, Salami SS, George A, Kaffenberger SD, Miller DC, Hearn JWD, Jolly S, Mehra R, Hollenbeck BK, Palapattu GS, Schipper M, Feng FY, Morgan TM, Desai NB, Spratt DE.
Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival.
Eur Urol. 2018 Jan 3. pii: S0302-2838(17)31070-9. doi: 10.1016/j.eururo.2017.12.023. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Kang HW, Jung HD, Lee JY, Kwon JK, Jeh SU, Cho KS, Ham WS, Choi YD.
Prediction of organ-confined disease after robot-assisted radical prostatectomy in patients with clinically locally-advanced prostate cancer.
Asian J Surg. 2017 Dec 20. pii: S1015-9584(17)30440-2. doi: 10.1016/j.asjsur.2017.10.005. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Rathbun JT, Schroeder TM, Eberhardt SC.
High postprostatectomy prostate-specific antigen level prior to salvage radiation therapy is not always a bad sign.
Rev Urol. 2017;19(3):190-194. doi: 10.3909/riu0754.
Source | Abstract | Full text | Similar articles




Tinay I, Aslan G, Kural AR, Özen H, Akdoğan B, Yıldırım A, Ongün Ş, Özkan A, Esen T, Zorlu F, Dillioğlugil Ö, Bekiroglu N, Türkeri L; Members of Urooncology Association.
Pathologic Outcomes of Candidates for Active Surveillance Undergoing Radical Prostatectomy: Results from a Contemporary Turkish Patient Cohort.
Urol Int. 2018;100(1):43-49. doi: 10.1159/000481266. Epub 2017 Dec 22.
Source | Abstract | Full text | Similar articles



TREATMENT


Choudhury A.
ProtecTing Low-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):515-517. doi: 10.1016/j.ijrobp.2016.10.021.
Source | Abstract | Full text | Similar articles




Ferdinandus J, Violet J, Sandhu S, Hofman MS.
Prostate-specific membrane antigen theranostics: therapy with lutetium-177.
Curr Opin Urol. 2018 Mar;28(2):197-204. doi: 10.1097/MOU.0000000000000486.
Source | Abstract | Full text | Similar articles




Hegemann M, Maas M, Rausch S, Walz S, Bedke J, Stenzl A, Todenhöfer T.
Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancer.
Asian J Androl. 2017 Dec 29. doi: 10.4103/aja.aja_59_17. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Rodriguez JF, Liauw SL, Eggener SE.
Managing Cancer Relapse After Radical Prostatectomy: Adjuvant Versus Salvage Radiation Therapy.
Urol Clin North Am. 2017 Nov;44(4):597-609. doi: 10.1016/j.ucl.2017.07.011.
Source | Abstract | Full text | Similar articles